BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7157195)

  • 1. Teratogenic and clastogenic effects of BUdR in mice.
    Franz J; Kleinebrecht J
    Teratology; 1982 Oct; 26(2):195-202. PubMed ID: 7157195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of 5-bromodeoxyuridine on fusion of the cranial neural folds in the mouse embryo.
    Bannigan JG
    Teratology; 1985 Oct; 32(2):229-39. PubMed ID: 4049281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cellular effect of 5-bromodeoxyuridine on the mammalian embryo.
    Bannigan J; Langman J
    J Embryol Exp Morphol; 1979 Apr; 50():123-35. PubMed ID: 458350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Teratogenic effects of sodium valproate in mice and rats at midgestation and at term.
    Menegola E; Broccia ML; Nau H; Prati M; Ricolfi R; Giavini E
    Teratog Carcinog Mutagen; 1996; 16(2):97-108. PubMed ID: 8875740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Embryo-lethal and teratogenic effect of the new platinum compound DPR in pregnant mice.
    Ognio E; Lapide M; Ottone M; Mandys V; Peterka M; Parodi B; Viale M
    Arch Toxicol; 2003 Oct; 77(10):584-90. PubMed ID: 14574446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct exposure of postimplantation mouse embryos to 5-bromodeoxyuridine in vitro and its effect on subsequent chondrogenesis in the limbs.
    Agnish ND; Kochhar DM
    J Embryol Exp Morphol; 1976 Dec; 36(3):623-38. PubMed ID: 1034666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporation of 5-bromo-2'-deoxyuridine into mesenchymal limb-bud cells destined to die: relationship to polydactyly induction in rats.
    Wise LD; Scott WJ
    J Embryol Exp Morphol; 1982 Dec; 72():125-41. PubMed ID: 6763934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Teratogenic and cytogenetic effects of some plant-derived antitumor agents (vincristine, colchicine, maytansine, VP-16-213 and VM-26) in mice.
    Sieber SM; Whang-Peng J; Botkin C; Knutsen T
    Teratology; 1978 Aug; 18(1):31-47. PubMed ID: 694777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Teratogenic effect of cyclophosphamide and the preventive effects of pyrithinoldehydrochloride monohydrate.
    Reznik G; Hecht J
    Arzneimittelforschung; 1979; 29(3):479-82. PubMed ID: 582733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposure to 5-bromo-2'-deoxyuridine induces oxidative stress and activator protein-1 DNA binding activity in the embryo.
    Sahambi SK; Hales BF
    Birth Defects Res A Clin Mol Teratol; 2006 Aug; 76(8):580-91. PubMed ID: 16955493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inhibition of embryonic histone deacetylases as the possible mechanism accounting for axial skeletal malformations induced by sodium salicylate.
    Di Renzo F; Cappelletti G; Broccia ML; Giavini E; Menegola E
    Toxicol Sci; 2008 Aug; 104(2):397-404. PubMed ID: 18483001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced expression of limb malformations and axial skeleton alterations in legless mutants by transplacental exposure to retinoic acid.
    Scott WJ; Collins MD; Ernst AN; Supp DM; Potter SS
    Dev Biol; 1994 Jul; 164(1):277-89. PubMed ID: 8026630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of bromodeoxyuridine-induced polydactyly.
    Scott WJ
    Teratology; 1981 Jun; 23(3):383-9. PubMed ID: 7256661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic risk assessment of etoposide from mouse bone marrow.
    Choudhury RC; Palo AK; Sahu P
    J Appl Toxicol; 2004; 24(2):115-22. PubMed ID: 15052606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additional endpoints and overview of a mouse skeletal variant assay for detecting exposure to teratogens.
    Beck SL
    Teratology; 1993 Feb; 47(2):147-57. PubMed ID: 8446928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the teratogenic potential of delalutin (17 alpha-hydroxyprogesterone caproate) in mice.
    Seegmiller RE; Nelson GW; Johnson CK
    Teratology; 1983 Oct; 28(2):201-8. PubMed ID: 6648824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An anticancer drug prospidine: failure to reveal antimitotic and clastogenic action on regenerating mouse liver.
    Uryvaeva IV; Sokolova AS; Faktor VM; Chernov VA; Brodsky WYa
    Neoplasma; 1983; 30(4):457-62. PubMed ID: 6888609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Teratogenic effects of retinoic acid are modulated in mice lacking expression of epidermal growth factor and transforming growth factor-alpha.
    Abbott BD; Best DS; Narotsky MG
    Birth Defects Res A Clin Mol Teratol; 2005 Apr; 73(4):204-17. PubMed ID: 15799028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP technical report on the toxicity studies of Riddelliine (CAS No. 23246-96-0) Administered by Gavage to F344 Rats and B6C3F1 Mice.
    Chan P
    Toxic Rep Ser; 1993 Dec; 27():1-D9. PubMed ID: 12209179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of median facial clefts in mice treated with methotrexate.
    Darab DJ; Minkoff R; Sciote J; Sulik KK
    Teratology; 1987 Aug; 36(1):77-86. PubMed ID: 3672380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.